Running head: MDR colonization dynamics
Abstract Background
Antimicrobial resistance (AMR) is highly prevalent in low-and middle-income countries.
International travel contributes substantially to the global spread of intestinal multidrugresistant gram-negative (MDR-GN) bacteria. Of the 100 million annual visitors to tropical countries, 30-70% become colonized by MDR-GN bacteria. The phenomenon has been well documented, but since sampling has only been conducted after travelers' return home, data on the actual colonization process are scarce.
Methods
A group of 20 European volunteers visiting Lao People's Democratic Republic for three weeks provided daily stool samples and filled in daily questionnaires. Acquisition of extendedspectrum beta-lactamase-producing gram-negative bacteria (ESBL-GN) was examined by selective stool cultures followed by whole-genome sequencing (WGS) of isolates.
Results
While colonization rates were 70% at the end of the study, daily sampling revealed that all participants had acquired ESBL-GN at some time point during their overseas stay, the status varying day by day. WGS analysis ascribed the transient pattern of colonization to sequential acquisition of new strains, resulting in a loss of detectable colonization by the initial MDR-GN strains. All but one participant acquired multiple strains (2) (3) (4) (5) . Of the total of 83 unique strains identified (53 E. coli, 10 Klebsiella, 20 other ESBL-GN species), some were shared by as many as four subjects.
Introduction
Antimicrobial resistance (AMR) poses a serious threat to human health worldwide [1] . The rapid global spread of multidrug-resistant (MDR) clones of Escherichia coli, Klebsiella pneumoniae and other Enterobacteriaceae raises an alarming public health concern [1].
Worldwide dissemination of successful clones such as E. coli ST131 has been the primary driver in extended-spectrum beta-lactamase (ESBL)-producing E. coli (ESBL-Ec) becoming prevalent among clinical isolates [2, 3] . Correspondingly, the global spread of carbapenemaseproducing clones of E. coli such as ST410 [4] and ST167 [5] , and K. pneumoniae clones such as CG258 and ST11 [6, 7] largely accounts for the rapid emergence of carbapenem resistance in clinical isolates of gram-negative pathogens worldwide.
The literature shows international travel to be strongly associated with acquisition of MDR-GN strains, mostly ESBL-Ec [8] [9] [10] [11] [12] [13] [14] [15] . The carriage rate of intestinal MDR-GN bacteria is highest among inhabitants of the Indian subcontinent and Southeast Asia, followed by Africa and South America [16] . Not surprisingly, travelers visiting these high-risk regions are at substantial risk of acquiring MDR-GN bacteria [15] . Colonization occurs even during short visits [8] [9] [10] [11] [12] [13] [14] [15] and without antimicrobial use [17] and can last for months or even over a year [8, 12, 13] and lead to further spread after return home [8, 13] . Genome-level analysis of MDR strains colonizing travelers shows that newly acquired MDR strains tend to displace resident intestinal commensal E. coli strains alongside new non-MDR strains, such that the pre-travel population remains as a minority [18] .
In previous studies of travelers' intestinal colonization by MDR-GN bacteria, samples have been taken immediately prior to travel and upon return to home country [8] [9] [10] [11] [12] [13] [14] . As such the 6 dynamics of this competitive colonization process are unknown. Here we present a longitudinal study carried out with volunteers visiting the Lao People's Democratic Republic (Laos). Combining daily samples from these travelers during their stay and fine-scale genomic analysis enabled us to demonstrate that colonization by MDR-GN bacteria is a highly dynamic process. We detected constant switching between the circulating MDR-GN stains acquired by individual hosts. Our finding of identical strains colonizing multiple individuals suggests common sources of acquisition or transmission between travelers. We also show colonization by strains with an alarming prevalence of mcr colistin resistance genes which belong to lineages not previously reported as high-risk AMR clones.
Methods

Study design
We characterised the colonization process by ESBL-GN through sampling stools on arrival, each day abroad, and at departure. The specimens were examined for presumptive ESBL-GN by culture, and the isolates were analyzed by whole-genome sequencing. The study protocol was approved by the Ethics Committee of the Helsinki University Hospital and the Ethikkommission Nordwest-und Zentralschweiz. All subjects provided written informed consent.
Volunteers, samples, and travel destination
Volunteers were recruited prospectively among participants at a medical course held 19
September -9 October, 2015 in Vientiane, Laos. We also invited the recruitees' companions to volunteer. While staying there, each volunteer was asked to provide daily stool samples.
Those collected within the first two days were considered as baseline samples and the final stools as departure samples. Questionnaires assessing background information and travelrelated data were used at recruitment and before departure. During the stay, the volunteers were asked to complete a health card to record gastrointestinal symptoms, food habits, and medication use each day. Travelers' diarrhea (TD) was defined as passage of ≥ 3 loose or liquid stools per day. Any ESBL-GN not found in the baseline samples but detected in one or more stool samples taken later were defined as travel-acquired ESBL-GN. Only volunteers providing at least five daily samples were included in the final subject group (Figure 1 ).
Stool cultures and phenotypic susceptibility testing
The initial screening for presumptive ESBL-GN strains from stool samples was conducted in 
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Illumina genome sequence reads were trimmed using Trimmomatic (V 0.3) [19] with a sliding window quality of Q15. De novo assembled genomes were produced using SPAdes (V 3.13.0) [20] . Resulting assembled genomes were annotated using Prokka (V 1.11) [21] . Antibiotic resistance genes were detected in assembled and annotated genomes using Abricate (V 0.8.7, https://github.com/tseemann/abricate) and the Resfinder database. Prokka-annotated genomes were manually inspected to confirm the presence of resistance genes identified. 
Results
Description of participants, travel, and symptoms during stay
A total of 23 volunteers were recruited, three of whom had to be later excluded for having only provided two samples (of note, ESBL-GN was found in them all). The final study population thus comprised 20 European volunteers (for demographics, see Table 1 ). Of the volunteers, 50% were aged < 50 years, 55% were female, 19 of them MDs participating at a medical course. The median age was 42.5 years (IQR 33.5−57.0), and the median duration of stay in Laos was 20 (IQR 12−21) days. Five participants (25%) had used antimicrobial medication during the previous year, three (15.0%) arrived directly from another tropical 9 region, one (5%) had visited the tropics within the past three months and seven (35%) within the last year ( Table 1) . The group provided a total of 236 stool samples.
Over the sampling period, the volunteers stayed at three separate hotels, lunched and dined at various restaurants either in small groups or all together, and participated in daily rounds at local hospitals. On the first or second weekend, most volunteers visited the cities of Luang Prabang or Vang Vieng. Four of the twenty contracted TD, and one took antibiotics. (12), Enterobacter cloacae (11) , and a number of other low-prevalence species including
Aeromonas spp. and Stenotrophomonas maltophilia (Table S1 ). When allocating individual isolates to the participants, colonization by any given ESBL-GN during the study period was clearly transient in nature, with isolates detected in only one or a few samples obtained from any given individual, sometimes with days between isolation.
Genomic analyses of isolates identified competition for colonization both at strain and species level
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The genomes of all 306 isolates were found to contain at least one antimicrobial resistance gene. The most prevalent ESBL gene type was blaCTX-M, found in a total of 226 isolates (74%), For example, participant 34, who took azithromycin for TD on 21-23 September, was transiently colonized by five different E. coli strains over the study period, each with different bla gene repertoires. Participant 16 showed a regular flux between isolation of an ST38, ST93, and ST101 strain, whilst participant 40 had initial colonization by an ST48 strain later displaced by an ST38. All these strains have unique signatures of carriage of multiple bla genes, indicating that travelers are exposed to a large number of MDR-GN bacteria and MDRconferring genes during the initial colonization process.
Uncommon population structure of ESBL-GN isolates
We analyzed the population of E. coli isolates at MLST designation level (Figure 4 ). The most common E. coli sequence types identified were ST101, ST34, ST38, and ST195. These lineages are very uncommon in surveys of ESBL and carbapenem-resistant E. coli, both in Europe [3] and indeed in previous human isolates from Laos [22, 23] . Superimposing the presence of specific ESBL-Ec and mcr genes onto a phylogenetic tree of the E. coli isolates revealed blaCTX-M genes to be ubiquitous throughout the sampled population of isolates, with mcr genes also widely distributed across the population ( Figure S2 ). Analysis of the K. pneumoniae lineages showed isolates belonging predominantly to ST2176 and ST37, none of which are well characterized globally disseminated clones [6, 24] .
Fine-scale genomic analysis identified common strains infecting participants
When analyzing the population structure of the E. coli isolates, very little diversity was found in strains within each of the different lineages. To investigate relationships between isolates within the lineages, we carried out a high-resolution SNP analysis using the first isolated strain as a reference. Our data showed a number of common strains colonizing participants, often with zero SNPs' difference between them ( Figure 5 ). An identical ST515 strain colonized participants 6, 17, 33, and 5, whilst an identical ST38 colonized participants 5, 40, and 13.
Participants 19 and 34 shared an identical ST34 strain, whilst participants 6 and 21 shared an identical ST385 strain. Participant 11 was colonized on day 8 by an ST2067 also isolated from a sample from the travel companion of this participant the following day. With only one exception, those belonging to each of these clusters stayed at the same hotel and, according to the researchers' observations, tended to spend a lot of time together.
Discussion
The impact of travel on the global spread of multidrug-resistant E. coli is well documented. Of travelers returning from the Indian subcontinent and Southeast Asia, Africa or South Asia, 20-80% are colonized by MDR-GN bacteria, most commonly ESBL-Ec [8] [9] [10] [11] [12] [13] [14] [15] . This colonization can extend over a period of months or even over a year [8, 12, 13] . Whilst the phenomenon is well described, the dynamics of the colonization process and the competition involved have not been thoroughly characterized. Thus far, traveler studies have analyzed pre-and post-travel samples [8] [9] [10] [11] [12] [13] [14] , whereas the actual travel period has not been accurately covered.
Here we monitored 20 European visitors to Laos on a daily basis over a three-week stay.
Combining their personal data with fine-scale genomic analysis of the strains isolated from fecal samples, we demonstrated that establishing colonization by an ESBL-GN strain during travel to endemic regions is an extremely dynamic process. We identified a constant influx of newly acquired ESBL-GN strains in all but one of the twenty participants. Over the duration of their visits, the volunteers were colonized by up to five different strains, and often acquired multiple ESBL-GN species. Few traveler studies have employed genome-level analyses [18] , but several have reported isolating more than one new colonizing ESBL-GN strain from posttravel samples [10] [11] [12] [13] [14] . Our data reveal the true scale and complexity at which drug-resistant bacteria colonize the intestinal tract during travel, demonstrating that it has been seriously underestimated. In addition, our data clearly show that several of our participants lost some of their travel-acquired ESBL-GN strains while still abroad. This indicates that previous studies solely employing pre-and post-travel sampling have under-reported the actual extent to which travelers are colonized by ESBL-GN. There is a potential caveat to our study in that the apparent cyclic disappearance and re-appearance of strains may be related to the sensitivity of the culture methods used, and colonizing strains may occasionally have been missed when picking colonies for sequencing.
Our fine-scale genomic analysis enabled identification of a number of strains shared by our volunteers. Some of the strains colonized up to four participants, often with zero SNPs' difference across the entire genome, and with a maximum of five SNPs' difference between 13 shared strains. Participants sharing strains stayed at the same hotels and spent time in each other's company. In one exceptional instance, two participants, X and Y (participant designations; X an author of this paper) staying in separate accommodations were found to share an identical strain ( Figure 5 ). These two participants had a point of contact, X taking a shower in Y's bathroom. Whilst direct transmission cannot be confirmed, the clonality of the isolates suggests that the two colonization events did not result from exposure to a common environmental reservoir. Such reservoirs are generally colonized by bacteria for extended periods of time, which leads to extensive diversity within the bacterial population [25, 26] .
Thus, direct transmission or acquisition through common exposure such as consumption of food or water appears the most likely explanation.
The population of ESBL-Ec isolates in this study has an unexpected composition.
Epidemiological surveys of multidrug-resistant E. coli, especially those focusing on ESBL strains, are dominated by E. coli ST131 [27] . Epidemiological investigations carried out on E. coli in Laos have also shown ST131 to be the dominant drug-resistant lineage in the country [22, 23] . However, we isolated no ST131 strains, and ST38 was the only lineage in our study that has been reported in studies previously conducted in Laos. They had investigated both intestinal colonization isolates [23] and clinical blood stream isolates [22] , suggesting that the ESBL-Ec population in Laos may be particularly dynamic and prone to frequent fluctuation.
Interestingly, ST101, ST34, and ST195, and other lineages frequently isolated in our study have never been reported as clinical ESBL-Ec isolates in countries such as the United Kingdom where high-quality longitudinal data are available [3] . Some reports describe ESBL-Ec ST101 [28] , but none report ST34 or ST195. E. coli ST38 has been extensively reported as an ESBL-Ec strain isolated both from humans and animals [29] [30] [31] .
Most previous studies among travelers have only described acquisition of ESBL-E. coli. A few have reported multiple findings of ESBL-DEC (diarrheagenic E. coli) [32] or single findings of ESBL-Klebsiella [11, 14] or carbapenemase-producing E. coli [12, 13] . Our data show, in addition to ESBL-E. coli (219 of 306 strains, 72%) a substantial number of ESBL-producing non-E. coli Gram-negative bacteria, such as Citrobacter (9%), Klebsiella (5%), Acinetobacter (4%),
and Enterobacter cloacae (4%) and even low numbers of Aeromonas spp. and
Stenotrophomonas maltophilia. This finding may be ascribed to an especially high rate of exposure to a variety of MDR-GN bacteria, since 19 of our volunteers attended a course of tropical medicine which included daily clinical rounds at local hospitals. High MDR-GN colonization rates have been reported among travelers hospitalized in the tropics [33] .
The complete absence of carbapenemase-producing E. coli in these samples is also noteworthy. We screened for ESBL-producing strains, but carbapenemase producers would also have grown on the selective plates used. However, WGS analysis showed a complete absence of carbapenemase genes, a finding somewhat surprising in Southeast Asia where the prevalence of carbapenem-resistant Enterobacteriaceae is increasing [34] . Such isolates have only recently been reported in Laos [35] , suggesting that carbapenem resistance has not yet become a major problem in the country. Even more striking were the extremely high levels of the mobile colistin resistance gene mcr in our E. coli isolates. The ST101 lineage which dominated our isolate collection has been identified as a driving lineage in the emergence of ESBL-Ec, and mcr positive E. coli in the region [36] , but we observed the mcr gene across a large number of lineages, a finding which may be of substantial importance. This confirms earlier reports showing that travel exacerbates the global spread of not only ESBL genes but also E. coli strains carrying mobile colistin resistance genes [37] .
By combining real-time sampling of travelers with genome-level analyses, we have demonstrated that colonization by ESBL-GN during travel is an extremely dynamic process characterized by competition between resistant strains and an individual's own microbiota.
We have also shown that prevalent strains can colonize multiple travelers via shared routes such as transmission or acquisition from a common source. The challenge now lies in unraveling the mechanisms that underlie this process and competition between the clones, as well as finding tools to prevent colonization already at its initial stages.
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